1. Home
  2. INDP vs JVA Comparison

INDP vs JVA Comparison

Compare INDP & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • JVA
  • Stock Information
  • Founded
  • INDP 2000
  • JVA 1971
  • Country
  • INDP United States
  • JVA United States
  • Employees
  • INDP N/A
  • JVA N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • INDP Health Care
  • JVA Consumer Staples
  • Exchange
  • INDP Nasdaq
  • JVA Nasdaq
  • Market Cap
  • INDP 5.0M
  • JVA 19.5M
  • IPO Year
  • INDP N/A
  • JVA 2005
  • Fundamental
  • Price
  • INDP $10.53
  • JVA $4.32
  • Analyst Decision
  • INDP Strong Buy
  • JVA
  • Analyst Count
  • INDP 2
  • JVA 0
  • Target Price
  • INDP $8.50
  • JVA N/A
  • AVG Volume (30 Days)
  • INDP 689.1K
  • JVA 240.6K
  • Earning Date
  • INDP 08-11-2025
  • JVA 06-13-2025
  • Dividend Yield
  • INDP N/A
  • JVA N/A
  • EPS Growth
  • INDP N/A
  • JVA 856.08
  • EPS
  • INDP N/A
  • JVA 0.65
  • Revenue
  • INDP N/A
  • JVA $84,651,329.00
  • Revenue This Year
  • INDP N/A
  • JVA N/A
  • Revenue Next Year
  • INDP N/A
  • JVA N/A
  • P/E Ratio
  • INDP N/A
  • JVA $6.58
  • Revenue Growth
  • INDP N/A
  • JVA 15.86
  • 52 Week Low
  • INDP $7.56
  • JVA $1.50
  • 52 Week High
  • INDP $66.64
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • INDP 49.39
  • JVA 53.52
  • Support Level
  • INDP $8.71
  • JVA $4.10
  • Resistance Level
  • INDP $13.44
  • JVA $4.60
  • Average True Range (ATR)
  • INDP 2.03
  • JVA 0.42
  • MACD
  • INDP 0.34
  • JVA 0.00
  • Stochastic Oscillator
  • INDP 24.05
  • JVA 45.06

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: